Pfizer - 50 Year Stock Price History | PFE
Historical daily share price chart and data for Pfizer since 1972 adjusted for splits. The latest closing stock price for Pfizer as of September 07, 2022 is 46.13.
- The all-time high Pfizer stock closing price was 59.84 on December 16, 2021.
- The Pfizer 52-week high stock price is 61.71, which is 33.8% above the current share price.
- The Pfizer 52-week low stock price is 40.94, which is 11.3% below the current share price.
- The average Pfizer stock price for the last 52 weeks is 50.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pfizer Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
50.3862 |
55.3492 |
55.3883 |
45.0345 |
46.1300 |
-20.04% |
| 2021 |
40.5652 |
34.6014 |
59.8436 |
31.8230 |
57.6941 |
66.74% |
| 2020 |
32.2340 |
33.5002 |
40.0064 |
24.6347 |
34.6014 |
3.18% |
| 2019 |
33.5853 |
35.6969 |
37.2843 |
29.0232 |
33.5344 |
-6.92% |
| 2018 |
31.8372 |
29.0386 |
38.1565 |
27.0468 |
36.0271 |
24.82% |
| 2017 |
26.6901 |
25.3062 |
29.6443 |
23.8875 |
28.8633 |
15.88% |
| 2016 |
24.7445 |
23.5996 |
28.0893 |
21.3089 |
24.9074 |
4.46% |
| 2015 |
24.5230 |
22.3909 |
26.2793 |
22.2694 |
23.8434 |
7.10% |
| 2014 |
21.3113 |
21.0239 |
22.9341 |
19.6267 |
22.2623 |
5.30% |
| 2013 |
19.7153 |
17.3046 |
22.2249 |
17.2646 |
21.1413 |
26.22% |
| 2012 |
15.2367 |
14.1228 |
17.2313 |
13.6062 |
16.7498 |
20.41% |
| 2011 |
12.3138 |
10.9075 |
14.0328 |
10.6038 |
13.9107 |
28.77% |
| 2010 |
10.1428 |
11.2069 |
11.8404 |
8.5406 |
10.8027 |
0.31% |
| 2009 |
9.1398 |
10.2620 |
11.1596 |
6.6931 |
10.7688 |
8.26% |
| 2008 |
10.4826 |
12.0585 |
12.6743 |
8.1163 |
9.9474 |
-16.85% |
| 2007 |
12.9936 |
13.2211 |
14.2226 |
11.7375 |
11.9638 |
-8.15% |
| 2006 |
12.6959 |
11.5278 |
14.1895 |
11.0676 |
13.0250 |
15.22% |
| 2005 |
12.1961 |
12.4405 |
13.7901 |
9.9862 |
11.3048 |
-10.62% |
| 2004 |
15.3309 |
16.3799 |
17.9004 |
11.4246 |
12.6475 |
-22.31% |
| 2003 |
14.5710 |
14.2574 |
16.5149 |
12.9780 |
16.2786 |
17.76% |
| 2002 |
15.6331 |
17.7804 |
18.7831 |
11.6284 |
13.8233 |
-22.16% |
| 2001 |
18.4820 |
20.3491 |
20.3491 |
15.7732 |
17.7581 |
-12.49% |
| 2000 |
18.2497 |
13.9395 |
21.5256 |
13.1524 |
20.2917 |
43.06% |
| 1999 |
16.7775 |
17.8517 |
21.7344 |
13.8004 |
14.1843 |
-21.50% |
| 1998 |
14.7096 |
10.8574 |
18.2275 |
10.6063 |
18.0685 |
68.94% |
| 1997 |
8.0312 |
5.7995 |
11.1615 |
5.7995 |
10.6953 |
81.93% |
| 1996 |
5.1474 |
4.3363 |
6.4101 |
4.2318 |
5.8789 |
33.96% |
| 1995 |
3.3343 |
2.5901 |
4.6149 |
2.5430 |
4.3885 |
66.69% |
| 1994 |
2.1938 |
2.2500 |
2.6793 |
1.7877 |
2.6327 |
15.31% |
| 1993 |
2.0973 |
2.3324 |
2.4400 |
1.7519 |
2.2831 |
-2.28% |
| 1992 |
2.3927 |
2.6541 |
2.7094 |
2.1119 |
2.3363 |
-11.97% |
| 1991 |
1.8573 |
1.2378 |
2.7094 |
1.1530 |
2.6541 |
112.74% |
| 1990 |
1.0406 |
1.0577 |
1.2591 |
0.8426 |
1.2476 |
20.49% |
| 1989 |
0.9218 |
0.8304 |
1.1136 |
0.7859 |
1.0354 |
24.15% |
| 1988 |
0.7594 |
0.6730 |
0.8465 |
0.6730 |
0.8340 |
29.22% |
| 1987 |
0.9015 |
0.8508 |
1.0498 |
0.5762 |
0.6454 |
-22.90% |
| 1986 |
0.8270 |
0.6862 |
0.9984 |
0.6450 |
0.8371 |
20.48% |
| 1985 |
0.6345 |
0.5540 |
0.7651 |
0.5231 |
0.6948 |
19.83% |
| 1984 |
0.4897 |
0.4958 |
0.5798 |
0.4117 |
0.5798 |
18.18% |
| 1983 |
0.5289 |
0.4649 |
0.6141 |
0.4649 |
0.4906 |
3.81% |
| 1982 |
0.4146 |
0.3602 |
0.5472 |
0.3448 |
0.4726 |
29.34% |
| 1981 |
0.3376 |
0.3654 |
0.3757 |
0.2796 |
0.3654 |
0.00% |
| 1980 |
0.2850 |
0.2573 |
0.3654 |
0.2239 |
0.3654 |
35.28% |
| 1979 |
0.2288 |
0.2273 |
0.2796 |
0.2007 |
0.2701 |
18.83% |
| 1978 |
0.2180 |
0.1878 |
0.2633 |
0.1750 |
0.2273 |
21.03% |
| 1977 |
0.1834 |
0.1973 |
0.1973 |
0.1612 |
0.1878 |
-6.43% |
| 1976 |
0.1937 |
0.1947 |
0.2144 |
0.1750 |
0.2007 |
4.91% |
| 1975 |
0.2050 |
0.2204 |
0.2504 |
0.1647 |
0.1913 |
-14.56% |
| 1974 |
0.2275 |
0.2968 |
0.3027 |
0.1483 |
0.2239 |
-24.56% |
| 1973 |
0.3011 |
0.2993 |
0.3594 |
0.2668 |
0.2968 |
0.88% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$256.821B |
$81.288B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
